<DOC>
	<DOCNO>NCT02881749</DOCNO>
	<brief_summary>The clinical efficacy mechlorethamine gel ( Valchlor ) maintenance therapy low dose total skin electron beam therapy ( TSEBT ) treatment mycosis fungoides cutaneous T-cell lymphoma evaluate study . Subjects treat low dose TSEBT ( 12 Gy total ) period two week . After 30 day observation period confirmation disease stage downgrade IA IB , subject use Valchlor maintenance therapy course one year . The efficacy Valchlor maintenance drug follow clinically Modified Severity Weight Assessment Tool ( mSWAT ) percent body surface area measurement ( % BSA ) . Furthermore , subject follow histopathologically skin biopsy perform screen visit , immediately observation period , one month start maintenance period , twelve month start maintenance period ( 4 biopsy total ) .</brief_summary>
	<brief_title>Low Dose Total Skin Electron Beam Treatment ( TSEBT ) Followed Maintenance Valchlor Patients With Mycosis Fungoides</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma , T-Cell</mesh_term>
	<mesh_term>Mycoses</mesh_term>
	<mesh_term>Mycosis Fungoides</mesh_term>
	<mesh_term>Lymphoma , T-Cell , Cutaneous</mesh_term>
	<mesh_term>Mechlorethamine</mesh_term>
	<criteria>1 . Male Female â‰¥ 18 year age Documentation diagnosis evidence one clinical feature consistent Mycosis Fungoides cutaneous TCell lymphoma Written inform consent obtain subject subject 's legal representative ability subject comply requirement study Skin biopsy specimen representative lesion obtain screen study deem diagnostic Mycosis Fungoides principal investigator Eligible , opinion investigator , low dose TSEBT course two week . Availability subject observe 18 month postscreening evaluation . Life Expectancy great 6 month Pregnant breastfeed female Presence condition abnormality opinion investigator would compromise safety patient quality data Patients diagnose Sezary Syndrome . Sezary Syndrome equivalent mycosis fungoides develop Stage IVA/B B2 ( high blood tumor burden ) involvement , require aggressive treatment regimen Valchlor TSEBT . Patients disease downgrade stage IA IB 30 day follow low dose TSEBT . Underlying medical condition include unstable cardiac disease , serious illness would impair ability patient undergo treatment Minimum 3 week since prior systematic treatment phototherapy Decisionallyimpaired individual , prisoner , vulnerable population</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>